Catalogo · 9780309253154
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020
ISBN 9780309253154
Descrizione non disponibile per questo libro.
La tua libreria
Accedi per aggiungere questo libro alla tua libreria.
Lettori
Communitas attorno al libro
Letture affini
Understanding the benefits and risks of pharmaceuticals
Leslie A. Pray, Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation
Transforming Clinical Research in the United States : Challenges and Opportunities
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Robert B. Giffin, Yeonwoo Lebovitz
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Steve Olson
Reflections on Sharing Clinical Trial Data : Challenges and a Way Forward
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Jennifer Hinners, Eeshan Khandekar, Theresa Wizemann
Real-World Evidence Generation and Evaluation of Therapeutics
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne
Public Engagement and Clinical Trials : New Models and Disruptive Technologies
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English
International Regulatory Harmonization amid Globalization of Drug Development
Forum on Drug Discovery, Development, and Translation Staff, Board on Health Sciences Policy, Institute of Medicine, Tracy A. Lustig, Victoria Weisfeld
Examining the Impact of Real-World Evidence on Medical Product Development
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Carolyn Shore
Enabling Precision Medicine : The Role of Genetics in Clinical Drug Development
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Forum on Drug Discovery, Development, and Translation
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Denise Caruso, Rebecca A. English, Anne B. Claiborne, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Robert Giffin, Sally Robinson
Dostoevsky and Kant
Evgenia Cherkasova
Verba volant · scripta manent